AZTA · Azenta, Inc.
$33.38
-0.53 (-1.56%)
At close · Aug 14
Market Cap
$1.46B
Shares
43.81M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Erik J. Bello | Vice President, Chief Accounting Officer | Appointed | 2026-08-11 |
| William "Trey" E. Martin III | President of its Multiomics business | Appointed | 2026-04-07 |
| Alan P. Malus | Board of Directors | Resigned | 2026-02-02 |
| Violetta Hughes | Vice President and Chief Accounting Officer (Principal Accounting Officer) | Resigned | 2025-07-02 |
| Ephraim Starr | Senior Vice President, General Counsel and Secretary | Appointed | 2025-05-16 |
| Jason W. Joseph | Senior Vice President, General Counsel and Secretary | Resigned | 2025-05-16 |
| David Wang | President of Sample Management Solutions | Terminated | 2025-04-09 |
| William Cornog | member of the Board | Appointed | 2024-11-04 |
| Alan Malus | member of the Board | Appointed | 2024-11-04 |
| Quentin Koffey | member of the Board | Appointed | 2024-11-04 |
| Stephen Schwartz | President and Chief Executive Officer | Retired | 2024-09-04 |
| John Marotta | member of the Board | Appointed | 2024-09-04 |
| John Marotta | President and Chief Executive Officer | Appointed | 2024-09-04 |
| Dr. Stephen Schwartz | director | Resigned | 2024-05-09 |
| Lindon Robertson | Executive Vice President and Chief Financial Officer | Retired | 2023-09-26 |
| Herman Cueto | Executive Vice President and Chief Financial Officer | Appointed | 2023-09-26 |
| Alfred Woollacott, III | Board of Directors | Retired | 2022-11-14 |
| Mark S. Wrighton | Board of Directors | Retired | 2022-11-14 |
| Matthew McManus | Chief Operating Officer | Terminated | 2022-10-17 |
Key facts
CIK
933974
CUSIP
114340102
13F (30d)
248 filings
235 filers
Visit website
Investor relations